An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...
Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple ...
Ascension improving maternal outcomes by reducing complications and disparities through integrated care and community health navigation programs.
CHRISTUS Health secures a $2.4 million Texas grant to enhance clinical simulation training for rural clinicians.
Based on the 21-item Anaphylaxis Quality of Life Scale for Adults, after the intervention, quality of life was slightly but ...
IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has ...
Health clinics and urgent care centers in Central Mississippi are strengthening infection control through specialized ...
More than 128,000 Floridians are living with HIV. The state has the second-highest rate of new HIV diagnoses after Georgia, with approximately 4,500 new diagnoses in 2023, the most recent year for ...
Cost concerns among GLP-1 users extend beyond individual financial strain to perceptions of broader health care system sustainability. More than 70% of respondents supported minimum coverage ...
Beam Therapeutics (NASDAQ:BEAM) outlined a new liver-targeted development program for phenylketonuria (PKU) and announced a large, non-dilutive financing tied to its sickle cell disease launch plans ...
An Iowa nursing home worker who was criminally charged with stealing residents’ painkillers has agreed to surrender her license. According to the Iowa Board of Nursing, Tanya Lynn Jordan worked at ...
Dayno emphasized, “Guiding WAKIX to blockbuster status in 2026, extending the WAKIX franchise with pitolisant GR's target PDUFA date in Q1 2027, expanding the pitolisant franchise with the advancement ...